Ordinary Rebalance | Solactive China Healthcare Disruption Index | Effective Date 3rd June 2024
Solactive China Healthcare Disruption Index:
In the ordinary rebalance, effective open 03.06.2024 the following index composition was implemented:
| AKESO INC | 6.7806 % |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 8.8843 % |
| ALPHAMAB ONCOLOGY | 0.0514 % |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 0.3397 % |
| CHINA RESOURCES PHARMACEUTICAL | 6.4741 % |
| CSPC PHARMACEUTICAL GROUP LTD | 8.8706 % |
| GENSCRIPT BIOTECH CORP | 3.7804 % |
| GRAND PHARMACEUTICAL GROUP LTD | 0.3668 % |
| HANSOH PHARMACEUTICAL GROUP CO | 7.7986 % |
| HUTCHMED CHINA LTD | 0.5143 % |
| INNOVENT BIOLOGICS INC | 7.7846 % |
| JD HEALTH INTERNATIONAL INC | 0.4778 % |
| KANGJI MEDICAL HOLDINGS LTD | 0.1533 % |
| KEYMED BIOSCIENCES INC | 0.1888 % |
| LEPU BIOPHARMA CO LTD-H | 0.1736 % |
| LIVZON PHARMACEUTICAL GROUP INC | 5.8284 % |
| LUYE PHARMA GROUP LTD | 0.2113 % |
| PHARMARON BEIJING CO LTD-H | 0.4824 % |
| REMEGEN CO LTD-H | 0.4415 % |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD | 8.0186 % |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD | 4.5448 % |
| SHANGHAI MICROPORT MEDBOT GR | 2.4602 % |
| SHANGHAI PHARMACEUTICALS HOLDING CO LTD-H | 0.5129 % |
| SIMCERE PHARMACEUTICAL GROUP | 0.3205 % |
| SINO BIOPHARMACEUTICAL LTD ORD | 8.1406 % |
| SKB BIO-B ORD H | 0.4702 % |
| WUXI APPTEC CO LTD | 7.4558 % |
| WUXI BIOLOGICS CAYMAN INC | 7.0177 % |
| YICHANG HEC CHANGJIANG PHA-H | 1.1519 % |
| ZAI LAB LTD | 0.3044 % |